Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a multi-component combination therapy consisting of both pharmaceutical antivirals and traditional Chinese medicine (TCM) formulas, as well as glucose. The pharmaceutical components include alpha-interferon (a cytokine with antiviral and immunomodulatory effects), abidol (also known as arbidol, an antiviral that inhibits viral entry), and ribavirin (a nucleoside analog with broad-spectrum antiviral activity). The TCM components—Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, and Baimu Qingre Jiedu Paste—are herbal preparations traditionally used to support immune function, clear heat/toxins, or treat infections according to TCM theory. Glucose serves as a supportive agent for energy or intravenous administration. This combination has been studied in the context of integrated Chinese-Western medicine approaches for acute viral infections such as COVID-19[9]. Mechanistically, the pharmaceuticals target viral replication or modulate host immunity; the herbal pastes are believed to have immunomodulatory or anti-inflammatory effects based on traditional use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha-interferon + abidol + ribavirin + Buzhong Yiqi plus and minus formula + Huhuang Detoxicity Paste + Baimu Qingre Jiedu Paste + glucose.